Please Note
We brought you to this page based on your search query. If this isn't what you are looking for, you can continue to Search Results for ""
The maximum number of items you can export is 3,000. Please reduce your list by using the filtering tool to the left.

You Browsed By:

You Searched For:


The product image can not be displayed.

Research and analysis on public companies and their debt instruments.



  • 26 Jul 2016
    • Outlook for US homebuilders remains positive on employment growth, tight inventory
      The outlook for US homebuilders remains positive as the industry continues to benefit from modest wage and employment growth, tight inventory levels and attractive mortgage rates. Home affordability, while diminishing, remains solid in much of the country and a backdrop of rising housing starts and new home sales should help projected revenues of publicly rated homebuilders climb steadily both this year and next. Press Release l Full Report​​
  • 20 Jul 2016
    • US branded drug manufacturers face event risk from patent reviews
      The risks of inter partes reviews (IPR) for makers of branded drugs will emerge over the next 12 to 18 months. Although the invalidation of a patent or patent claim as a result of the procedure won’t necessarily lead to immediate generic competition, many drugs still face significant shortening of their patent lives due to IPR... Full Report l Press Release
  • 13 Jul 2016
    • Multiemployer pension plans remain substantially underfunded
      US multiemployer pension plans (MEPPs) remain substantially underfunded, threatening the viability of the Pension Benefit Guaranty Corporation’s (PBGC) insurance fund and potentially putting a financial strain on company sponsors. In an analysis of 124 MEPPs, we found that the plans were underfunded by a combined $337 billion at the end of 2014, equating to an average funding ratio of only about 47%... Full Report l Press Release
Please refine your search by Market Segment to get corresponding Rating Activity and Watchlist
Complete Your Profile
Please complete your profile before submitting your comments.
We're Sorry